Closed
SectorHealthcare
120.9 0.52
24h
Min
118.17
Max
121.26
Income | -95M 7.9M |
---|---|
Sales | -55M 573M |
P/E Sector Avg | 40.824 56.602 |
EPS | 0.7 |
Profit margin | 1.38 |
Employees | 1,800 |
EBITDA | -146M 24M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +34.8% upside |
Next Earnings | 31 Jul 2025 |
---|
Market Cap | 289M 12B |
---|---|
Previous open | 120.38 |
Previous close | 120.9 |
By Acuity
17%
83%
24 / 382 Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 160.11 USD 34.8%
High 192 USD
Low 115 USD
Based on 21 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$